Next Article in Journal
Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators
Previous Article in Journal
Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the RAD51C Gene
Previous Article in Special Issue
Plant-Derived Natural Compounds in Genetic Vaccination and Therapy for HPV-Associated Cancers

Human Papillomavirus and Cancers

Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, via Mariano Semmola, 80131 Naples, Italy
Authors to whom correspondence should be addressed.
Cancers 2020, 12(12), 3772;
Received: 24 November 2020 / Revised: 4 December 2020 / Accepted: 8 December 2020 / Published: 15 December 2020
(This article belongs to the Special Issue Human Papillomavirus and Cancers)
Note: In lieu of an abstract, this is an excerpt from the first page.

Persistent infection with oncogenic human papillomaviruses (HPVs) is the main cause of nearly all cervical cancers as well as of a significant proportion of other malignancies arising from the mucosal squamous epithelia of the anogenital tract as well as of the head and neck region [1]. [...] View Full-Text
MDPI and ACS Style

Tornesello, M.L.; Buonaguro, F.M. Human Papillomavirus and Cancers. Cancers 2020, 12, 3772.

AMA Style

Tornesello ML, Buonaguro FM. Human Papillomavirus and Cancers. Cancers. 2020; 12(12):3772.

Chicago/Turabian Style

Tornesello, Maria L.; Buonaguro, Franco M. 2020. "Human Papillomavirus and Cancers" Cancers 12, no. 12: 3772.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop